Abstract

Nowadays the problem of the antimicrobial resistance promotes the search of new chemical core-structures with the antimicrobial properties.Aim. To study the interaction of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide with active methylene nitriles and aliphatic aldehydes and assess the antimicrobial activity of the compounds obtained.Results and discussion. 1,2-Benzoxathiin-4(3H)-one 2,2-dioxide as a structural analog of 1,3-dicarbonyl compounds was used in the three-component interaction with aliphatic aldehydes and active methylene nitriles. In the case of malononitrile the target compounds were formed. When using ethyl cyanoacetate the only isolated product was triethylammonium salt that could be also obtained by the two-component reaction of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide with aliphatic aldehydes. The study of the antimicrobial properties showed the higher activity of the compounds studied than in the reference drugs, especially against gram-positive strains.Experimental part. The series of 2-amino-4-alkyl-4,6-dihydropyrano[3,2-c][2,1]benzoxathiin-3-carbonitrile 5,5-dioxides and triethylammonium 3-[1-(4-hydroxy-2,2-dioxido-1,2-benzoxathiin-3-yl)alkyl]-1,2-benzoxathiin-4-olate 2,2-dioxides was synthesized. The antimicrobial activity of the compounds obtained was determined by the agar “well” diffusion method.Conclusions. It has been shown that 1,2-benzoxathiin-4(3H)-one 2,2-dioxide as a structural analog of 1H-2,1-benzothiazin-4-one 2,2-dioxide can be used in similar three- and two-component reactions, but its reactivity is less due to the replacement of the 1-N-R-group with an O-atom. The novel compounds obtained exceeded the antimicrobial activity of the reference drugs, and were more active against gram-positive bacteria in contrast to isosteric derivatives of 1H-2,1-benzothiazin-4-one 2,2-dioxide that were active against gram-negative strains and fungi.

Highlights

  • It has been shown that 1,2-benzoxathiin-4(3H)-one 2,2-dioxide as a structural analog of 1H-2,1-benzothiazin-4-one 2,2-dioxide can be used in similar three- and two-component reactions, but its reactivity is less due to the replacement of the 1-N-R-group with an O-atom

  • The novel compounds obtained exceeded the antimicrobial activity of the reference drugs, and were more active against gram-positive bacteria in contrast to isosteric derivatives of 1H-2,1-benzothiazin-4-one 2,2-dioxide that were active against gram-negative strains and fungi

  • The series of 2-amino-4-alkyl-4,6-dihydropyrano [3,2-c][2,1]benzoxathiin-3-carbonitrile 5,5-dioxides has been synthesized based on the three-component interaction of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide with malononitrile and aliphatic aldehydes

Read more

Summary

Conclusions

18 18 sions” (Kyiv) concerning innovations in the healthcare system. 1. The series of 2-amino-4-alkyl-4,6-dihydropyrano [3,2-c][2,1]benzoxathiin-3-carbonitrile 5,5-dioxides has been synthesized based on the three-component interaction of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide with malononitrile and aliphatic aldehydes. 2. Using ethyl cyanoacetate in the same interaction did not lead to the desired ethyl 2-amino-4H-pyran-3-carboxylates and in the case of isobutyric aldehyde resulted in formation of triethylammonium salt. Using ethyl cyanoacetate in the same interaction did not lead to the desired ethyl 2-amino-4H-pyran-3-carboxylates and in the case of isobutyric aldehyde resulted in formation of triethylammonium salt It is explained by two equiprobable reaction pathways. 3. By means of the two-component approach based on the interaction of 1,2-benzoxathiin-4(3H)-one 2,2-dioxide and aliphatic aldehydes the series of triethylammonium 3-[1-(4-hydroxy-2,2-dioxido-1,2-benzoxathiin-3-yl)alkyl]-1,2-benzoxathiin-4-olate 2,2-dioxides has been synthesized. Conflict of Interests: authors have no conflict of interests to declare

Experimental Part
Findings

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.